Friday 6 November 2026
Export CL’s income statement to Excel — free account
Colgate-Palmolive Company
CL Consumer Defensive Household & Personal Products
Colgate-Palmolive Company’s revenue for fiscal 2025 (year ended December 2025) was $20.4 billion, up 1.40% from fiscal 2024.
- Revenue
- +4.64%
- EPS
- +7.42%
- Free cash flow
- −6.24%
- Total debt
- −8.35%
Quarter to September 2026, against a year earlier
96.53
2.16
−2.19%
Follow CL
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 6 | 6 | 6 |
+8 more TTM periods Free account |
| 218.74% | 251.92% | 342.58% | 469.09% | ||
| 11.99% | 11.90% | 12.56% | 13.17% | ||
ROIC |
28.91% | 27.74% | 28.02% | 29.25% | |
Return on Tangible Assets |
47.43% | 42.47% | 43.77% | 60.64% | |
Average Days of Receivables |
32.60 | 34.03 | 33.16 | 30.00 | |
Free Cash Flow per Share |
4.75 | 4.83 | 4.70 | 4.49 | |
Free Cash Flow |
3,789.00 | 3,858.00 | 3,767.00 | 3,634.00 | |
Capital Expenditures |
(577.00) | (598.00) | (578.00) | (564.00) | |
| Other line items | |||||
Cash ROIC |
38.34% | 39.40% | 38.46% | 37.69% | |
Accounts Receivable Turnover |
11.48 | 11.27 | 11.51 | 12.75 | |
Accounts Payable Turnover |
4.23 | 4.27 | 4.26 | 4.18 | |
Inventory Turnover |
3.91 | 3.87 | 3.94 | 4.05 | |
Average Days of Payables |
91.26 | 92.69 | 92.12 | 93.78 | |
Days of Inventory on Hand |
95.01 | 95.58 | 91.68 | 91.22 | |
Tax Rate |
(0.27) | (0.26) | (0.26) | (0.26) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
39.41% | 39.19% | 38.86% | 38.77% | |
Share Based Compensation of Revenue |
0.79% | 0.85% | 0.83% | 0.76% | |
Interest Coverage |
12.69 | 12.32 | 12.14 | 12.38 | |
Operating CF/Net income |
2.13 | 2.19 | 2.08 | 1.97 | |
Depreciation/Fixed assets |
0.34 | 0.34 | 0.34 | 0.33 | |
Capex/Depreciation |
(0.37) | (0.38) | (0.37) | (0.36) | |
Revenue per Share |
26.71 | 26.33 | 25.92 | 25.20 | |
Operating CF per Share |
5.48 | 5.57 | 5.42 | 5.19 | |
Capex per Share |
(0.72) | (0.75) | (0.72) | (0.70) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 3 Nov 2026